Is there a role for digoxin in patients with systolic dysfunction?

Pharmacotherapy

Volumn 16, Issue 2 II, 1996, Pages

  Williamson, Kristin M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CAPTOPRIL; DESLANOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; MILRINONE; NORADRENALIN; RENIN; XAMOTEROL;

ALDOSTERONE BLOOD LEVEL; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG MECHANISM; EXERCISE TOLERANCE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INOTROPISM; MORTALITY; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; REVIEW; SINUS RHYTHM; SYMPATHETIC NERVE CELL; TREATMENT FAILURE;

DIGOXIN; HUMANS; RANDOMIZED CONTROLLED TRIALS; SYSTOLE; VENTRICULAR DYSFUNCTION;

EID: 0029875850     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. LaPiana-Simonsen L. What are pharmacists dispensing most often? Pharm Times 1991,57:57, 58, 61, 62, 64, 67-69, 71.
2. Jaeschke R, Oxman AD, Guyatt GH. To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. Am J Med 1990;88:279-86.
3. The CONSENSUS Trial Study Group. Effects of enalapnl on mortality in severe congestive heart failure. N Engl J Med 1987,316:1429-35.
4. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 1991,325.303-10.
5. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
6. Withering W. An account of the foxglove and some of its medical uses with practical remarks on dropsy and other diseases. In: Willins FA, Keyes TE, eds. Classics of cardiology New York: Henry Schuman, 1941:231-52.
7. Arnold SB, Byrd RC, Meister W, et al. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 1980;303:1443-8
8. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients direct evidence from sympathetic neural recordings. Circulation 1989;80:65-77.
9. Gheorghiade M, St Clair J, St Clair C, Beller GA. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 1987;9:849-57
10. Gheorghiade M, Ferguson D. Digoxin: a neurohormonal modulator in heart failure? Circulation 1991,84 2181-6.
11. Ferguson DW. Digitalis and neurohormonal abnormalities in heart failure and implications for therapy. Am J Cardiol 1992;69.24G-33.
12. Ribner HS, Plucinski DA, Hsieh AM, et al. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamichormonal study. Am J Cardiol 1985;56:896-904.
13. Krum H, Bigger JT Jr, Goldsmith RL, Packer M. Effect of longterm digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 1995;25:289-94.
14. Dobbs S, Kenyon W, Dobbs R. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J 1977,1:749-52.
15. Fleg J, Gottlieb S, Lakatta E. Is digoxin important in treatment of compensated heart failure? Am J Med 1982;73:244-50
16. Lee DC, Johnson RA, Bingham JB, et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med 1982,306:699-705
17. Taggart A, Johnston G, McDevitt D. Digoxin withdrawal after cardiac failure in patients with sinus rhythm. J Cardiovasc Pharmacol 1983;5:229-34
18. Guyatt GH, Sullivan MJ, Fallen EL, et al. A controlled trial of digoxin in congestive heart failure Am J Cardiol 1988;61 371-5.
19. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984;39.818-22.
20. German and Austrian Xamoterol Study Group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet 1988;1 489-93.
21. The Captopril-Digoxin Multicenter Study Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-44.
22. DiBianco R, Shabetal R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure N Engl J Med 1989;320:677-83.
23. Pugh SE, White NJ, Aronson JK, Grahame-Smith DG, Bloomfield JG. Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment. Br Heart J 1989;61:529-39.
24. Fleg J, Rothfeld B, Gottlieb S, Wright J. Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled crossover mal. J Am Coll Cardiol 1991;17:743-51.
25. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993,22.955-62.
26. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med 1993,329.1-7.
27. Konstant M, Dracup K, Baker D, et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction Clinical practice guideline 11 Rockville, MD Agency for Health Care Policy and Research, Public Health Service, U.S Department of Health and Human Services, 1994.